« Pomalidomide approved for use across Europe Amendments to the pharmacovigilance legislation: new notification requirements… »
Slovak translation of the MPE Report on Myeloma Patient Perspectives is now available Published October 31, 2013 Download your copy here. Recent news» EHA 2021| Daratumumab plus lenalidomide and dexamethasone (D-Rd) shows overall survival benefit in elderly patients with transplant-ineligible newly diagnosed myeloma» EHA 2021 | Daratumumab maintenance improves Progression-Free Survival (PFS) after autologous stem cell transplantation in myeloma Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment. I accept the Privacy Policy * for Click to select the duration you give consent until. Indefinite 1 Month 3 Months 6 Months
Leave a Reply